Like other GLP-1R agonists, when used alone or treated with non-insulin secretagogues, DUL treatment is associated with weight loss or decreased weight gain (107)
10.1016/j.molcel.2012.09.025 Mol
Nhng thc phm giu vitamin C c th k n nh tri cy h cam qut, da li, bng ci xanh, bp ci tm, kiwi, t chung, ci kale, mm brussels, i, du ty hoc qu mng ni chung, Ngoi cch ung Glutathione v vitamin C kt hp, bn cng c th kt hp L-Glutathione vi nhiu tinh cht thin nhin khc nh tinh cht Sakura (chit xut hoa anh o), Collagen, P.Leucotomos (chit xut cy dng x) v Pomegranate (chit xut lu ) trong vic lm trng da
Early results from preclinical and clinical studies have shown the potential benefits of GLP-1RAs in improving glycaemic control, weight management, endothelial function, atherosclerotic plaque stability, systemic inflammation, renal function, BP levels and AF risk
The potential involvement of a dopaminergic mechanism in this process was inferred from the blocking action of pimozide, a dopamine antagonist, on the DSIP-induced GH increase